36155067|t|Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population.
36155067|a|BACKGROUND: Till date, there is an obvious obscurity of specific and early diagnostic biomarkers for Alzheimer's disease (AD). The promising diagnostic potential of serum miRNAs is increasingly emerging; however, rare miRNAs data originates from middle and low-income countries to provide proper validation in these highly affected populations. This study evaluated the diagnostic value of serum miR-34a, miR-29b and miR-181c in Egyptian AD patients. METHODS: Expression levels of serum miR-34a, miR-29b and miR-181c were determined using quantitative real time PCR in AD patients versus healthy controls. Amyloid Beta 42 (Abeta42), Phosphorylated Tau (p-Tau) and TNF-alpha levels were also detected as distinctive AD markers. We further explored the correlation between miRNAs levels and Mini mental state examination (MMSE) scores. Finally, we conducted logistic regression and ROC curve analyses to evaluate the diagnostic values of the measured parameters. RESULTS: Sera miR-34a, miR-29b and miR-181c were significantly downregulated in AD patients and this decrease was associated with cognitive decline. AD patients manifested significant elevation of Abeta42, pTau and TNF-alpha levels. The measured miRNAs showed good AD diagnostic value solely and when used together (AUC = 0.77, 95 % C I. 0.62-0.93 at p < 0.01). Interestingly, combining miRNAs panel with Abeta42, TNF-alpha and pTau levels remarkably increased the diagnostic power (AUC = 0.97, 95 % C I. 0.94-1.00 at p < 0.001) achieving sensitivity 88.2 % and specificity 91.4 %. CONCLUSION: This study spots for the first time the diagnostic potential of serum miR-34a, miR-29b and miR-181c as minimally invasive AD biomarker panel in Egyptian patients and highlights their contribution in AD pathogenesis.
36155067	5	12	miR-34a	Gene	407040
36155067	14	21	miR-29b	Gene	407024
36155067	26	34	miR-181c	Gene	406957
36155067	85	95	Alzheimers	Disease	MESH:D000544
36155067	225	244	Alzheimer's disease	Disease	MESH:D000544
36155067	246	248	AD	Disease	MESH:D000544
36155067	520	527	miR-34a	Gene	407040
36155067	529	536	miR-29b	Gene	407024
36155067	541	549	miR-181c	Gene	406957
36155067	562	564	AD	Disease	MESH:D000544
36155067	565	573	patients	Species	9606
36155067	611	618	miR-34a	Gene	407040
36155067	620	627	miR-29b	Gene	407024
36155067	632	640	miR-181c	Gene	406957
36155067	693	695	AD	Disease	MESH:D000544
36155067	696	704	patients	Species	9606
36155067	747	754	Abeta42	Gene	351
36155067	772	775	Tau	Gene	4137
36155067	779	782	Tau	Gene	4137
36155067	788	797	TNF-alpha	Gene	7124
36155067	839	841	AD	Disease	MESH:D000544
36155067	1099	1106	miR-34a	Gene	407040
36155067	1108	1115	miR-29b	Gene	407024
36155067	1120	1128	miR-181c	Gene	406957
36155067	1165	1167	AD	Disease	MESH:D000544
36155067	1168	1176	patients	Species	9606
36155067	1215	1232	cognitive decline	Disease	MESH:D003072
36155067	1234	1236	AD	Disease	MESH:D000544
36155067	1237	1245	patients	Species	9606
36155067	1282	1289	Abeta42	Gene	351
36155067	1300	1309	TNF-alpha	Gene	7124
36155067	1350	1352	AD	Disease	MESH:D000544
36155067	1490	1497	Abeta42	Gene	351
36155067	1499	1508	TNF-alpha	Gene	7124
36155067	1749	1756	miR-34a	Gene	407040
36155067	1758	1765	miR-29b	Gene	407024
36155067	1770	1778	miR-181c	Gene	406957
36155067	1801	1803	AD	Disease	MESH:D000544
36155067	1832	1840	patients	Species	9606
36155067	1878	1880	AD	Disease	MESH:D000544
36155067	Positive_Correlation	MESH:D000544	351
36155067	Association	MESH:D000544	4137
36155067	Negative_Correlation	MESH:D003072	407024
36155067	Negative_Correlation	MESH:D000544	407040
36155067	Negative_Correlation	MESH:D000544	407024
36155067	Negative_Correlation	MESH:D000544	406957
36155067	Positive_Correlation	MESH:D000544	7124
36155067	Negative_Correlation	MESH:D003072	406957
36155067	Negative_Correlation	MESH:D003072	407040

